Fat Grafting for Facial Defect
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a two-step approach to improve facial appearance and tissue health in service members and veterans with facial injuries. It uses a person's own fat, taken from one part of the body, to fill areas of the face needing extra volume. Initially, the trial employs fresh fat (autologous fresh fat grafting) and, three months later, uses fat that has been frozen and stored (autologous cryopreserved fat grafting). The study seeks participants with facial injuries who have sufficient fat in other body areas for both treatments and have healed from any recent surgeries or injuries. As an unphased trial, it offers a unique opportunity to contribute to innovative treatment approaches for facial injuries.
Do I need to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are on medications that significantly impact wound healing, like immunosuppressive agents, chronic steroids, or chemotherapy, you may not be eligible to participate.
What prior data suggests that this two-stage fat grafting approach is safe for craniofacial reconstruction?
Research has shown that using a person's own fat for grafting is generally safe and well-tolerated. Studies highlight its benefits for correcting facial deformities. Most people do not experience serious side effects, and common minor issues like swelling or bruising usually resolve on their own.
In a study with 53 patients, fat stored at very low temperatures for later use proved safe for facial procedures. The patients did not report any major problems. This suggests that both fresh and stored fat grafting are safe options for those considering joining the trial.12345Why are researchers excited about this trial?
Unlike traditional reconstructive methods for facial defects, which often involve synthetic implants or skin grafts, autologous fresh fat grafting uses the patient's own fat tissue to restore facial contours. This approach is unique because it employs freshly harvested adipose tissue, reducing the risk of rejection and providing a more natural look and feel. Researchers are particularly excited about the two-stage process, with an initial graft followed by a cryopreserved fat graft at three months, which may enhance the sustainability and integration of the grafts over time. This technique not only offers a personalized treatment option but also holds promise for improved long-term outcomes in repairing craniofacial deformities.
What evidence suggests that this two-stage fat grafting approach is effective for craniofacial reconstruction?
This trial will evaluate the effectiveness of two-stage autologous fat grafting for facial defects. Studies have shown that using a patient's own fat to fill in areas can correct facial deformities and improve appearance. Research indicates that fresh fat, which participants will receive in the first stage, can effectively enhance the shape and look of faces with injuries. Initial findings suggest that a second treatment using frozen fat, administered in the second stage, can also be effective. Evidence shows that both fresh and frozen fat maintain their volume, meaning they stay in place and retain their shape over time. A review of various studies confirms that these procedures often succeed in reconstructive surgeries. Therefore, using both fresh and frozen fat appears promising for improving the health and appearance of facial tissue.12346
Who Is on the Research Team?
J. Peter Rubin
Principal Investigator
University of Pittsburgh
Patsy Simon, BS, RN, CCRC, CCRA, ACRP-PM
Principal Investigator
Director, Operations and Administration
Are You a Good Fit for This Trial?
This trial is for wounded service members and veterans with post-traumatic craniofacial deformities. Participants must be willing to undergo two fat grafting procedures: one with fresh fat and another with previously harvested and cryopreserved fat. They should also agree to provide medical and demographic data.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Treatment
Participants undergo an initial fat grafting procedure using freshly harvested adipose tissue.
Second Treatment
Participants receive a second fat grafting procedure 3 months after the first, using cryopreserved adipose tissue.
Follow-up
Participants are monitored for safety and effectiveness after the second treatment.
What Are the Treatments Tested in This Trial?
Interventions
- Autologous Cryopreserved Fat Grafting
- Autologous Fresh Fat Grafting
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
Armed Forces Institute of Regenerative Medicine
Collaborator